Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage

Christopher H Evans, F. J. Liu, V. Glatt, J. A. Hoyland, C. Kirker-Head, A. Walsh, O. Betz, J. W. Wells, V. Betz, R. M. Porter, F. A. Saad, L. C. Gerstenfeld, T. A. Einhorn, M. B. Harris, M. S. Vrahas

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

We report a novel technology for the rapid healing of large osseous and chondral defects, based upon the genetic modification of autologous skeletal muscle and fat grafts. These tissues were selected because they not only possess mesenchymal progenitor cells and scaffolding properties, but also can be biopsied, genetically modified and returned to the patient in a single operative session. First generation adenovirus vector carrying cDNA encoding human bone morphogenetic protein-2 (Ad.BMP-2) was used for gene transfer to biopsies of muscle and fat. To assess bone healing, the genetically modified ("gene activated") tissues were implanted into 5mm-long critical size, mid-diaphyseal, stabilized defects in the femora of Fischer rats. Unlike control defects, those receiving gene-activated muscle underwent rapid healing, with evidence of radiologic bridging as early as 10 days after implantation and restoration of full mechanical strength by 8 weeks. Histologic analysis suggests that the grafts rapidly differentiated into cartilage, followed by efficient endochondral ossification. Fluorescence in situ hybridization detection of Y-chromosomes following the transfer of male donor muscle into female rats demonstrated that at least some of the osteoblasts of the healed bone were derived from donor muscle. Gene activated fat also healed critical sized defects, but less quickly than muscle and with more variability. Anti-adenovirus antibodies were not detected. Pilot studies in a rabbit osteochondral defect model demonstrated the promise of this technology for healing cartilage defects. Further development of these methods should provide ways to heal bone and cartilage more expeditiously, and at lower cost, than is presently possible.

Original languageEnglish (US)
Pages (from-to)96-111
Number of pages16
JournalEuropean Cells and Materials
Volume19
StatePublished - Jan 2010
Externally publishedYes

Fingerprint

Cartilage
Oils and fats
Grafts
Muscle
Bone
Repair
Fats
Transplants
Bone and Bones
Muscles
Defects
Adenoviridae
Genes
Tissue Donors
Rats
Technology
Tissue
Y Chromosome
Gene transfer
Inbred F344 Rats

Keywords

  • Adenovirus
  • Animal models
  • Bone healing
  • Bone morphogenetic protein
  • Cartilage repair
  • Facilitated endogenous repair
  • Fibrodysplasia ossificans progressiva
  • Gene therapy
  • Large segmental defects
  • Tissue engineering

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Bioengineering
  • Biomedical Engineering
  • Biomaterials

Cite this

Evans, C. H., Liu, F. J., Glatt, V., Hoyland, J. A., Kirker-Head, C., Walsh, A., ... Vrahas, M. S. (2010). Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. European Cells and Materials, 19, 96-111.

Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. / Evans, Christopher H; Liu, F. J.; Glatt, V.; Hoyland, J. A.; Kirker-Head, C.; Walsh, A.; Betz, O.; Wells, J. W.; Betz, V.; Porter, R. M.; Saad, F. A.; Gerstenfeld, L. C.; Einhorn, T. A.; Harris, M. B.; Vrahas, M. S.

In: European Cells and Materials, Vol. 19, 01.2010, p. 96-111.

Research output: Contribution to journalArticle

Evans, CH, Liu, FJ, Glatt, V, Hoyland, JA, Kirker-Head, C, Walsh, A, Betz, O, Wells, JW, Betz, V, Porter, RM, Saad, FA, Gerstenfeld, LC, Einhorn, TA, Harris, MB & Vrahas, MS 2010, 'Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage', European Cells and Materials, vol. 19, pp. 96-111.
Evans CH, Liu FJ, Glatt V, Hoyland JA, Kirker-Head C, Walsh A et al. Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. European Cells and Materials. 2010 Jan;19:96-111.
Evans, Christopher H ; Liu, F. J. ; Glatt, V. ; Hoyland, J. A. ; Kirker-Head, C. ; Walsh, A. ; Betz, O. ; Wells, J. W. ; Betz, V. ; Porter, R. M. ; Saad, F. A. ; Gerstenfeld, L. C. ; Einhorn, T. A. ; Harris, M. B. ; Vrahas, M. S. / Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. In: European Cells and Materials. 2010 ; Vol. 19. pp. 96-111.
@article{7c29e7b6d8d145ba895f880b37659a0a,
title = "Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage",
abstract = "We report a novel technology for the rapid healing of large osseous and chondral defects, based upon the genetic modification of autologous skeletal muscle and fat grafts. These tissues were selected because they not only possess mesenchymal progenitor cells and scaffolding properties, but also can be biopsied, genetically modified and returned to the patient in a single operative session. First generation adenovirus vector carrying cDNA encoding human bone morphogenetic protein-2 (Ad.BMP-2) was used for gene transfer to biopsies of muscle and fat. To assess bone healing, the genetically modified ({"}gene activated{"}) tissues were implanted into 5mm-long critical size, mid-diaphyseal, stabilized defects in the femora of Fischer rats. Unlike control defects, those receiving gene-activated muscle underwent rapid healing, with evidence of radiologic bridging as early as 10 days after implantation and restoration of full mechanical strength by 8 weeks. Histologic analysis suggests that the grafts rapidly differentiated into cartilage, followed by efficient endochondral ossification. Fluorescence in situ hybridization detection of Y-chromosomes following the transfer of male donor muscle into female rats demonstrated that at least some of the osteoblasts of the healed bone were derived from donor muscle. Gene activated fat also healed critical sized defects, but less quickly than muscle and with more variability. Anti-adenovirus antibodies were not detected. Pilot studies in a rabbit osteochondral defect model demonstrated the promise of this technology for healing cartilage defects. Further development of these methods should provide ways to heal bone and cartilage more expeditiously, and at lower cost, than is presently possible.",
keywords = "Adenovirus, Animal models, Bone healing, Bone morphogenetic protein, Cartilage repair, Facilitated endogenous repair, Fibrodysplasia ossificans progressiva, Gene therapy, Large segmental defects, Tissue engineering",
author = "Evans, {Christopher H} and Liu, {F. J.} and V. Glatt and Hoyland, {J. A.} and C. Kirker-Head and A. Walsh and O. Betz and Wells, {J. W.} and V. Betz and Porter, {R. M.} and Saad, {F. A.} and Gerstenfeld, {L. C.} and Einhorn, {T. A.} and Harris, {M. B.} and Vrahas, {M. S.}",
year = "2010",
month = "1",
language = "English (US)",
volume = "19",
pages = "96--111",
journal = "European Cells and Materials",
issn = "1473-2262",
publisher = "Swiss Society for Biomaterials",

}

TY - JOUR

T1 - Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage

AU - Evans, Christopher H

AU - Liu, F. J.

AU - Glatt, V.

AU - Hoyland, J. A.

AU - Kirker-Head, C.

AU - Walsh, A.

AU - Betz, O.

AU - Wells, J. W.

AU - Betz, V.

AU - Porter, R. M.

AU - Saad, F. A.

AU - Gerstenfeld, L. C.

AU - Einhorn, T. A.

AU - Harris, M. B.

AU - Vrahas, M. S.

PY - 2010/1

Y1 - 2010/1

N2 - We report a novel technology for the rapid healing of large osseous and chondral defects, based upon the genetic modification of autologous skeletal muscle and fat grafts. These tissues were selected because they not only possess mesenchymal progenitor cells and scaffolding properties, but also can be biopsied, genetically modified and returned to the patient in a single operative session. First generation adenovirus vector carrying cDNA encoding human bone morphogenetic protein-2 (Ad.BMP-2) was used for gene transfer to biopsies of muscle and fat. To assess bone healing, the genetically modified ("gene activated") tissues were implanted into 5mm-long critical size, mid-diaphyseal, stabilized defects in the femora of Fischer rats. Unlike control defects, those receiving gene-activated muscle underwent rapid healing, with evidence of radiologic bridging as early as 10 days after implantation and restoration of full mechanical strength by 8 weeks. Histologic analysis suggests that the grafts rapidly differentiated into cartilage, followed by efficient endochondral ossification. Fluorescence in situ hybridization detection of Y-chromosomes following the transfer of male donor muscle into female rats demonstrated that at least some of the osteoblasts of the healed bone were derived from donor muscle. Gene activated fat also healed critical sized defects, but less quickly than muscle and with more variability. Anti-adenovirus antibodies were not detected. Pilot studies in a rabbit osteochondral defect model demonstrated the promise of this technology for healing cartilage defects. Further development of these methods should provide ways to heal bone and cartilage more expeditiously, and at lower cost, than is presently possible.

AB - We report a novel technology for the rapid healing of large osseous and chondral defects, based upon the genetic modification of autologous skeletal muscle and fat grafts. These tissues were selected because they not only possess mesenchymal progenitor cells and scaffolding properties, but also can be biopsied, genetically modified and returned to the patient in a single operative session. First generation adenovirus vector carrying cDNA encoding human bone morphogenetic protein-2 (Ad.BMP-2) was used for gene transfer to biopsies of muscle and fat. To assess bone healing, the genetically modified ("gene activated") tissues were implanted into 5mm-long critical size, mid-diaphyseal, stabilized defects in the femora of Fischer rats. Unlike control defects, those receiving gene-activated muscle underwent rapid healing, with evidence of radiologic bridging as early as 10 days after implantation and restoration of full mechanical strength by 8 weeks. Histologic analysis suggests that the grafts rapidly differentiated into cartilage, followed by efficient endochondral ossification. Fluorescence in situ hybridization detection of Y-chromosomes following the transfer of male donor muscle into female rats demonstrated that at least some of the osteoblasts of the healed bone were derived from donor muscle. Gene activated fat also healed critical sized defects, but less quickly than muscle and with more variability. Anti-adenovirus antibodies were not detected. Pilot studies in a rabbit osteochondral defect model demonstrated the promise of this technology for healing cartilage defects. Further development of these methods should provide ways to heal bone and cartilage more expeditiously, and at lower cost, than is presently possible.

KW - Adenovirus

KW - Animal models

KW - Bone healing

KW - Bone morphogenetic protein

KW - Cartilage repair

KW - Facilitated endogenous repair

KW - Fibrodysplasia ossificans progressiva

KW - Gene therapy

KW - Large segmental defects

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=84875951313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875951313&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84875951313

VL - 19

SP - 96

EP - 111

JO - European Cells and Materials

JF - European Cells and Materials

SN - 1473-2262

ER -